M. Fiona Shortt de Hernandez
@mfshortt.bsky.social
PhD, MBA | Associate Director @BioNTech | Technology Profiling | Formulation and Delivery Technologies | Biotech | Personal Account. Views mine.
#ChemSky #RNASky #MedSky #ImmunoSky
#ChemInclusion @cheminclusion.bsky.social
#ChemSky #RNASky #MedSky #ImmunoSky
#ChemInclusion @cheminclusion.bsky.social
Pinned
Ran the annual London Winter Run 10K @WinterRunUK for Cancer Research UK @CR_UK yesterday! An amazing experience as always & this time together with 25,000 other participants! A record number!!!🏃♀️🏃🏃♂️
Reposted by M. Fiona Shortt de Hernandez
BREAKING: Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi win the Nobel Prize in medicine for work on peripheral immune tolerance.
The Nobel Prize in medicine goes to 3 scientists for work on peripheral immune tolerance
Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi have won the Nobel Prize in medicine for their discoveries about peripheral immune tolerance.
bit.ly
October 6, 2025 at 9:41 AM
BREAKING: Mary E. Brunkow, Fred Ramsdell and Shimon Sakaguchi win the Nobel Prize in medicine for work on peripheral immune tolerance.
Reposted by M. Fiona Shortt de Hernandez
Das Pharmaunternehmen Biontech will den deutschen Konkurrenten Curevac übernehmen. Es gebe ein öffentliches Umtauschangebot für alle Aktien von Curevac, teilte Biontech in Mainz mit.
Biontech will Konkurrenten Curevac übernehmen
Das Pharmaunternehmen Biontech will den deutschen Konkurrenten Curevac übernehmen. Es gebe ein öffentliches Umtauschangebot für alle Aktien von Curevac, teilte Biontech in Mainz mit.
www.spiegel.de
June 12, 2025 at 11:08 AM
Das Pharmaunternehmen Biontech will den deutschen Konkurrenten Curevac übernehmen. Es gebe ein öffentliches Umtauschangebot für alle Aktien von Curevac, teilte Biontech in Mainz mit.
Great to be learning about the exciting new developments in AI for pharma at the Digital-Tech Pharma & AI conference in London this week!
May 29, 2025 at 6:19 AM
Great to be learning about the exciting new developments in AI for pharma at the Digital-Tech Pharma & AI conference in London this week!
It rained and poured this morning but what a day to run through VfB’s home stadium during the Stuttgart-Lauf 2025! #dfb #vfbstuttgart #stuttgartlauf #10K
May 25, 2025 at 2:36 PM
It rained and poured this morning but what a day to run through VfB’s home stadium during the Stuttgart-Lauf 2025! #dfb #vfbstuttgart #stuttgartlauf #10K
Reposted by M. Fiona Shortt de Hernandez
2026 will Biontech sein erstes Krebsmedikament auf den Markt bringen. Jetzt wird klar, wie die Mainzer dabei vorgehen.
Biontech: Neue Medikamente, neuer Vorstand
2026 will Biontech sein erstes Krebsmedikament auf den Markt bringen. Jetzt wird klar, wie die Mainzer dabei vorgehen.
www.wiwo.de
May 5, 2025 at 11:26 AM
2026 will Biontech sein erstes Krebsmedikament auf den Markt bringen. Jetzt wird klar, wie die Mainzer dabei vorgehen.
Reposted by M. Fiona Shortt de Hernandez
Ehrung für BioNTech-Mitgründer Türeci und Sahin#Nationalpreis#BioNTech
Ehrung für BioNTech-Mitgründer Türeci und Sahin
Jurychef der Deutschen Nationalstiftung, Mirow, sprach von einem "leuchtenden Beispiel".
www.tagesschau.de
March 26, 2025 at 2:54 PM
Ehrung für BioNTech-Mitgründer Türeci und Sahin#Nationalpreis#BioNTech
Reposted by M. Fiona Shortt de Hernandez
Newly published data from a phase 1 clinical trial on a #PancreaticCancer #mRNA #vaccine shows that patients whose cancer went into remission after receiving the vaccine remained cancer-free after three years.
Pancreatic cancer mRNA vaccine — exciting clinical trial results
BioNTech's pancreatic cancer mRNA vaccine candidate, cevumeran, has shown promising results in a phase 1 trial.
buff.ly
March 8, 2025 at 8:00 PM
Newly published data from a phase 1 clinical trial on a #PancreaticCancer #mRNA #vaccine shows that patients whose cancer went into remission after receiving the vaccine remained cancer-free after three years.
Reposted by M. Fiona Shortt de Hernandez
Happy #InternationalWomensDay 🎉
#IUPAC 2025 Awards for Distinguished Women in #Chemistry 👩🔬 #ChemicalEngineering
Yu-Ju Chen
Stefanie Dehnen
Hemda Garelick
Marie-Claude Heuzey
Young-Shin Jun
Tanja Junkers
Zhang Lin
Zhimin Liu
Jane Catherine Ngila
Ah-Hyung Alissa Park
Vivian W.W. Yam
Xuehua Zhang
#IUPAC 2025 Awards for Distinguished Women in #Chemistry 👩🔬 #ChemicalEngineering
Yu-Ju Chen
Stefanie Dehnen
Hemda Garelick
Marie-Claude Heuzey
Young-Shin Jun
Tanja Junkers
Zhang Lin
Zhimin Liu
Jane Catherine Ngila
Ah-Hyung Alissa Park
Vivian W.W. Yam
Xuehua Zhang
March 8, 2025 at 11:39 AM
Happy #InternationalWomensDay 🎉
#IUPAC 2025 Awards for Distinguished Women in #Chemistry 👩🔬 #ChemicalEngineering
Yu-Ju Chen
Stefanie Dehnen
Hemda Garelick
Marie-Claude Heuzey
Young-Shin Jun
Tanja Junkers
Zhang Lin
Zhimin Liu
Jane Catherine Ngila
Ah-Hyung Alissa Park
Vivian W.W. Yam
Xuehua Zhang
#IUPAC 2025 Awards for Distinguished Women in #Chemistry 👩🔬 #ChemicalEngineering
Yu-Ju Chen
Stefanie Dehnen
Hemda Garelick
Marie-Claude Heuzey
Young-Shin Jun
Tanja Junkers
Zhang Lin
Zhimin Liu
Jane Catherine Ngila
Ah-Hyung Alissa Park
Vivian W.W. Yam
Xuehua Zhang
Reposted by M. Fiona Shortt de Hernandez
Happy #InternationalWomensDay! Today, we celebrate the brilliant women shaping the future of #chemistry. From research to mentorship, their impact is undeniable. Let’s break barriers, amplify voices, and create a more inclusive STEM community! Who inspires you? Tag them! #IWD #ChemInclusion
March 8, 2025 at 1:13 PM
Happy #InternationalWomensDay! Today, we celebrate the brilliant women shaping the future of #chemistry. From research to mentorship, their impact is undeniable. Let’s break barriers, amplify voices, and create a more inclusive STEM community! Who inspires you? Tag them! #IWD #ChemInclusion
Reposted by M. Fiona Shortt de Hernandez
The summer call of our International PhD programme is open! 📢
Ready to advance your scientific career? If you're passionate about #RNAbiology, #Bioinformatics, or #Immunology, apply to our open calls and join our global community of over 200 #PhD students! 🌍
www.imb.de/phd
Ready to advance your scientific career? If you're passionate about #RNAbiology, #Bioinformatics, or #Immunology, apply to our open calls and join our global community of over 200 #PhD students! 🌍
www.imb.de/phd
February 17, 2025 at 10:46 AM
The summer call of our International PhD programme is open! 📢
Ready to advance your scientific career? If you're passionate about #RNAbiology, #Bioinformatics, or #Immunology, apply to our open calls and join our global community of over 200 #PhD students! 🌍
www.imb.de/phd
Ready to advance your scientific career? If you're passionate about #RNAbiology, #Bioinformatics, or #Immunology, apply to our open calls and join our global community of over 200 #PhD students! 🌍
www.imb.de/phd
Reposted by M. Fiona Shortt de Hernandez
Robert-Koch-Postdoktorandenpreis für den Themenbereich Immunologie (€ 5.000) / Bewerbungsschluss: 14. März 2025
Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie.
Mehr Informationen unter: dgfi.org/preise/koch-...
Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie.
Mehr Informationen unter: dgfi.org/preise/koch-...
February 28, 2025 at 3:00 PM
Robert-Koch-Postdoktorandenpreis für den Themenbereich Immunologie (€ 5.000) / Bewerbungsschluss: 14. März 2025
Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie.
Mehr Informationen unter: dgfi.org/preise/koch-...
Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie.
Mehr Informationen unter: dgfi.org/preise/koch-...
Exciting results from BioNTech in collaboration with Genentech for the treatment of pancreatic cancer using an mRNA-lipoplex vaccine. #RNASky rdcu.be/eb4Lj
RNA neoantigen vaccines prime long-lived CD8+ T cells in pancreatic cancer
Nature - In a phase 1 trial, patients with pancreatic ductal adenocarcinoma who were treated with surgery and bespoke neoantigen mRNA vaccines combined with anti-PD-L1 and chemotherapy exhibited...
rdcu.be
March 3, 2025 at 10:54 PM
Exciting results from BioNTech in collaboration with Genentech for the treatment of pancreatic cancer using an mRNA-lipoplex vaccine. #RNASky rdcu.be/eb4Lj
Ran the annual London Winter Run 10K @WinterRunUK for Cancer Research UK @CR_UK yesterday! An amazing experience as always & this time together with 25,000 other participants! A record number!!!🏃♀️🏃🏃♂️
February 24, 2025 at 3:53 PM
Ran the annual London Winter Run 10K @WinterRunUK for Cancer Research UK @CR_UK yesterday! An amazing experience as always & this time together with 25,000 other participants! A record number!!!🏃♀️🏃🏃♂️
Reposted by M. Fiona Shortt de Hernandez
From breaking barriers to building the future - women and girls are shaping our world with discovery, innovation and courage. Let’s celebrate their brilliance and inspire the next generation!#WomenInScience #InternationalDayofWomenandGirlsinScience #ChemInclusion
February 11, 2025 at 5:32 PM
From breaking barriers to building the future - women and girls are shaping our world with discovery, innovation and courage. Let’s celebrate their brilliance and inspire the next generation!#WomenInScience #InternationalDayofWomenandGirlsinScience #ChemInclusion
Reposted by M. Fiona Shortt de Hernandez
Interested in undertaking a PhD in the transformative field #mRNA cancer vaccines? I have an earmarked #PhD scholarship available for an outstanding domestic student to join our team at UQ and @basemrna.bsky.social. If this sounds like you, get in touch.
study.uq.edu.au/study-option...
study.uq.edu.au/study-option...
January 31, 2025 at 5:41 AM
Interested in undertaking a PhD in the transformative field #mRNA cancer vaccines? I have an earmarked #PhD scholarship available for an outstanding domestic student to join our team at UQ and @basemrna.bsky.social. If this sounds like you, get in touch.
study.uq.edu.au/study-option...
study.uq.edu.au/study-option...
Reposted by M. Fiona Shortt de Hernandez
We are looking for a postdoc to join the Knight Group! Interested in the interface of peptide and polymer chemistry with applications in therapeutics and nanomaterials? Send questions or an application with a cover letter, CV, and statement of previous research. #chempostdoc
www.knightgroupunc.org
www.knightgroupunc.org
The Knight Group - UNC
www.knightgroupunc.org
January 14, 2025 at 3:03 AM
We are looking for a postdoc to join the Knight Group! Interested in the interface of peptide and polymer chemistry with applications in therapeutics and nanomaterials? Send questions or an application with a cover letter, CV, and statement of previous research. #chempostdoc
www.knightgroupunc.org
www.knightgroupunc.org
Reposted by M. Fiona Shortt de Hernandez
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - @erturklab.bsky.social @hendrikdietz.bsky.social go.nature.com/4gNLjeC
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - Nature Biotechnology
An integrated experimental and deep learning pipeline reveals cell-level targeting of nanocarriers in whole bodies.
go.nature.com
January 14, 2025 at 5:21 PM
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning - @erturklab.bsky.social @hendrikdietz.bsky.social go.nature.com/4gNLjeC
Reposted by M. Fiona Shortt de Hernandez
Mit dem Covid-Impfstoff hat das Mainzer Unternehmen Biontech Milliarden Euro verdient. Nun setzen seine Gründer Uğur Şahin und Özlem Türeci dieses Geld ein, um an ihrem eigentlichen Lebenswerk zu arbeiten: den Krebs endgültig zu besiegen. Kann es dem Paar gelingen?
Mit KI gegen Krebs: Wie Biontech zum zweiten Mal Medizingeschichte schreiben will
Mit dem Covid-Impfstoff hat das Mainzer Unternehmen Biontech Milliarden Euro verdient. Nun setzen seine Gründer Uğur Şahin und Özlem Türeci dieses Geld ein, um an ihrem eigentlichen Lebenswerk zu arbeiten: den Krebs endgültig zu besiegen. Kann es dem Paar…
www.spiegel.de
February 4, 2024 at 9:22 AM
Mit dem Covid-Impfstoff hat das Mainzer Unternehmen Biontech Milliarden Euro verdient. Nun setzen seine Gründer Uğur Şahin und Özlem Türeci dieses Geld ein, um an ihrem eigentlichen Lebenswerk zu arbeiten: den Krebs endgültig zu besiegen. Kann es dem Paar gelingen?
Reposted by M. Fiona Shortt de Hernandez
Happy launch day everyone! We're really excited to share our first issue, which is now available to read online here www.nature.com/nrct/
January 15, 2025 at 3:21 PM
Happy launch day everyone! We're really excited to share our first issue, which is now available to read online here www.nature.com/nrct/
Reposted by M. Fiona Shortt de Hernandez
I could not be more thrilled to announce the Nature Methods @naturemethods.bsky.social Method of the Year is Spatial Proteomics! Please see our editorial as a roadmap to the fantastic content in this special issue! www.nature.com/articles/s41...
Method of the Year 2024: spatial proteomics - Nature Methods
Approaches for profiling the spatial proteome in tissues are the basis of atlas-scale projects that are delivering on their promise for understanding biological complexity in health and disease.
www.nature.com
December 6, 2024 at 8:52 PM
I could not be more thrilled to announce the Nature Methods @naturemethods.bsky.social Method of the Year is Spatial Proteomics! Please see our editorial as a roadmap to the fantastic content in this special issue! www.nature.com/articles/s41...
Reposted by M. Fiona Shortt de Hernandez
The blood-brain barrier can prevent therapeutic drugs from reaching the brain.
Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6
Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6
A claudin5-binding peptide enhances the permeability of the blood-brain barrier in vitro
A claudin5 binding peptide enhances transport across the blood-brain barrier by transiently permeabilizing tight junctions.
scim.ag
January 15, 2025 at 5:46 PM
The blood-brain barrier can prevent therapeutic drugs from reaching the brain.
Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6
Researchers in #ScienceAdvances have identified a peptide that increases the barrier’s permeability, showing potential for more effective drug delivery to treat brain diseases. scim.ag/4jhnWf6
Reposted by M. Fiona Shortt de Hernandez
I made a starter pack for interesting people in the mRNA vaccines and therapeutics space. Message me if you want to be added. #RNAsky
go.bsky.app/VSHfBce
go.bsky.app/VSHfBce
November 25, 2024 at 5:57 AM
I made a starter pack for interesting people in the mRNA vaccines and therapeutics space. Message me if you want to be added. #RNAsky
go.bsky.app/VSHfBce
go.bsky.app/VSHfBce